{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Test%2FControl&page=6", "query": { "intervention": "Test/Control", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 4495, "total_pages": 450, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Test%2FControl&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Test%2FControl&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T13:50:16.881Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03970447", "title": "A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Glioblastoma" ], "interventions": [ { "name": "Temozolomide", "type": "DRUG" }, { "name": "Lomustine", "type": "DRUG" }, { "name": "Regorafenib", "type": "DRUG" }, { "name": "Radiation", "type": "RADIATION" }, { "name": "Paxalisib", "type": "DRUG" }, { "name": "VAL-083", "type": "DRUG" }, { "name": "VT1021", "type": "DRUG" }, { "name": "Troriluzole", "type": "DRUG" }, { "name": "ADI-PEG 20", "type": "BIOLOGICAL" }, { "name": "AZD1390", "type": "DRUG" }, { "name": "Tinostamustine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "RADIATION", "BIOLOGICAL" ], "sponsor": "Global Coalition for Adaptive Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2250, "start_date": "2019-07-30", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 42, "location_summary": "Birmingham, Alabama • La Jolla, California • Los Angeles, California + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03970447" }, { "nct_id": "NCT05846971", "title": "Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Barrett Esophagus", "Esophageal Cancer" ], "interventions": [ { "name": "Educational materials on validated methylation assay", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Capsulomics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2021-01-26", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2023-05-06", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846971" }, { "nct_id": "NCT02922816", "title": "FMT for MDRO Colonization After Infection in Renal Transplant Recipients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Infection Due to Resistant Organism" ], "interventions": [ { "name": "Fecal Microbiota Transplant (FMT)", "type": "BIOLOGICAL" }, { "name": "Bowel preparation", "type": "PROCEDURE" }, { "name": "Stool or perirectal swab sampling", "type": "PROCEDURE" }, { "name": "Fasting", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2016-12-01", "completion_date": "2021-12-03", "has_results": false, "last_update_posted_date": "2023-11-15", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02922816" }, { "nct_id": "NCT00098306", "title": "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Maraviroc (UK-427,857)", "type": "DRUG" }, { "name": "Optimized Background Therapy", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 601, "start_date": "2004-11", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-04-27", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 20, "location_summary": "Sacramento, California • San Francisco, California • Auroa, Colorado + 14 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Auroa", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00098306" }, { "nct_id": "NCT00688584", "title": "Ultra-brief Intervention for Problem Drinkers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Problem Drinking", "Alcoholism" ], "interventions": [ { "name": "Pamphlet-based personalized alcohol feedback (PAF)", "type": "BEHAVIORAL" }, { "name": "control pamphlet condition", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Centre for Addiction and Mental Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 1767, "start_date": "2008-12", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2013-04-09", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 2, "location_summary": "Stanford, California • Seattle, Washington", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00688584" }, { "nct_id": "NCT02584426", "title": "Subcutaneous Injection and Ultrasonic Dispersion of Cefazolin Into Chronic Pelvic-Region Pressure Ulcers in Persons With Spinal Cord Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injury", "Chronic Pressure Ulcers" ], "interventions": [ { "name": "Ultrasonic Distribution of Cefazolin", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "James J. Peters Veterans Affairs Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 1, "start_date": "2017-01", "completion_date": "2022-03", "has_results": false, "last_update_posted_date": "2022-04-25", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02584426" }, { "nct_id": "NCT03370978", "title": "Text Messaging Follow-up From ED", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Text Messaging" ], "interventions": [ { "name": "Text Messaging", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-05-01", "completion_date": "2020-05-01", "has_results": false, "last_update_posted_date": "2021-04-30", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03370978" }, { "nct_id": "NCT05838872", "title": "Evaluation of the Accuracy and Usability of the Minuteful - Kidney Urine Analysis Test System in the Lay User Hands", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Albuminuria", "Chronic Kidney Diseases", "Diabetes", "Hypertension" ], "interventions": [ { "name": "Minuteful - Kidney Urine Analysis Test System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Healthy.io Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 216, "start_date": "2021-12-09", "completion_date": "2022-07-15", "has_results": false, "last_update_posted_date": "2023-05-03", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 1, "location_summary": "Garden City, New York", "locations": [ { "city": "Garden City", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05838872" }, { "nct_id": "NCT01925339", "title": "Esthetic Outcomes of Immediately Placed Implants Receiving Immediate Provisionalization and Delayed Restoration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tooth Diseases", "Tooth Extraction", "Dental Implant" ], "interventions": [ { "name": "Test (immediate restoration)", "type": "DEVICE" }, { "name": "Control: delayed restoration", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 40, "start_date": "2015-12", "completion_date": "2018-03-15", "has_results": true, "last_update_posted_date": "2019-02-18", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01925339" }, { "nct_id": "NCT03137992", "title": "Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Test Product (tiotropium bromide inhalation powder)", "type": "DRUG" }, { "name": "Reference Product (Spiriva®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lupin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 377, "start_date": "2017-11-21", "completion_date": "2018-04-30", "has_results": true, "last_update_posted_date": "2021-04-05", "last_synced_at": "2026-10-20T13:50:16.881Z", "location_count": 34, "location_summary": "Andalusia, Alabama • Jasper, Alabama • Glendale, Arizona + 28 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03137992" } ] }